Concepedia
Statistics
Publications
13
Citations
951
H-Index
12
Active since
2016
Affiliations
Biogen (United States)(Current)
Shenyang Normal University
Butler Hospital
National Research Tomsk State University
Amsterdam UMC Location Vrije Universiteit Amsterdam
Ying Tian is an author at Biogen (United States) specializing in alzheimer disease, dementia, and medicine.
Publications per year
2016–2024
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
Stephen Salloway, Spyros Chalkias, Frederik Barkhof et al. · JAMA Neurology · 2021 · 584 citations · Full text
Medicine, Neurology, Pharmacology +16
Clinical Development of Aducanumab, an Anti-Aβ Human Monoclonal Antibody Being Investigated for the Treatment of Early Alzheimer's Disease.
Samantha Budd Haeberlein, John O’Gorman, Ping-Chun Chiao et al. · PubMed · 2017 · 86 citations
Pharmacy, Pharmacology, Pharmacotherapy +17
Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease
Samantha Budd Haeberlein, Christian von Hehn, Ying Tian et al. · Alzheimer s & Dementia · 2020 · 78 citations · Full text
Medicine, Neurology, Pharmacology +17
Association of Grandparental and Parental Age at Childbirth With Autism Spectrum Disorder in Children
Yu Gao, Yongfu Yu, Jingyuan Xiao et al. · JAMA Network Open · 2020 · 49 citations · Full text
Public Health, Child Health, Pediatrics +14
Results from the long‐term extension of PRIME: A randomized Phase 1b trial of aducanumab
Tianle Chen, John O’Gorman, Carmen Castrillo‐Viguera et al. · Alzheimer s & Dementia · 2024 · 30 citations · Full text
1–5 of 13